Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1034

1.

28Structural insights into substrate recognition and catalysis by glycoside hydrolase family 87 α-1,3-glucanase from Paenibacillus glycanilyticus FH11.

Itoh T, Intuy R, Suyotha W, Hayashi J, Yano S, Makabe K, Wakayama M, Hibi T.

FEBS J. 2019 Dec 2. doi: 10.1111/febs.15161. [Epub ahead of print]

PMID:
31788942
2.

Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis.

Suzuki Y, Watanabe M, Matsui T, Motoya S, Hisamatsu T, Yuasa H, Tabira J, Isogawa N, Tsuchiwata S, Arai S, Hibi T.

Inflamm Intest Dis. 2019 Oct;4(4):131-143. doi: 10.1159/000502144. Epub 2019 Aug 8.

3.

Activation of ERK Is Associated with Hepatocellular Carcinoma with Aggressive Phenotypes.

Minagawa T, Yamazaki K, Masugi Y, Tsujikawa H, Ojima H, Hibi T, Abe Y, Yagi H, Kitago M, Shinoda M, Itano O, Kitagawa Y, Sakamoto M.

Hepatol Res. 2019 Nov 8. doi: 10.1111/hepr.13445. [Epub ahead of print]

PMID:
31702093
4.

Methicillin-resistant Staphylococcus aureus carriers are vulnerable to bloodstream infection after living donor liver transplantation.

Takemura Y, Hibi T, Shinoda M, Obara H, Minagawa T, Kitago M, Yagi H, Abe Y, Matsubara K, Oshima G, Hori S, Hoshino K, Yamada Y, Itano O, Takano Y, Kuroda T, Hasegawa N, Kitagawa Y.

Clin Transplant. 2019 Nov 6:e13753. doi: 10.1111/ctr.13753. [Epub ahead of print]

PMID:
31692105
5.

Crystal structure of the catalytic unit of GH 87-type α-1,3-glucanase Agl-KA from Bacillus circulans.

Yano S, Suyotha W, Oguro N, Matsui T, Shiga S, Itoh T, Hibi T, Tanaka Y, Wakayama M, Makabe K.

Sci Rep. 2019 Oct 25;9(1):15295. doi: 10.1038/s41598-019-51822-5.

6.

Structural and biochemical characterisation of a novel alginate lyase from Paenibacillus sp. str. FPU-7.

Itoh T, Nakagawa E, Yoda M, Nakaichi A, Hibi T, Kimoto H.

Sci Rep. 2019 Oct 16;9(1):14870. doi: 10.1038/s41598-019-51006-1.

7.

Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan.

Tajiri H, Arai K, Kagimoto S, Kunisaki R, Hida N, Sato N, Yamada H, Nagano M, Susuta Y, Ozaki K, Kondo K, Hibi T.

BMC Pediatr. 2019 Oct 13;19(1):351. doi: 10.1186/s12887-019-1739-5.

8.

A Multicenter Japanese Survey Assessing the Long-Term Outcomes of Liver Retransplantation using Living Donor Grafts.

Kuramitsu K, Fukumoto T, Egawa H, Ohdan H, Umeshita K, Uemoto S, Hibi T, Kasahara M, Yoshizumi T, Mizuta K, Shimamura T, Furukawa H.

Transplantation. 2019 Sep 13. doi: 10.1097/TP.0000000000002958. [Epub ahead of print]

PMID:
31568214
9.

Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis.

Yamashita T, Ueda M, Nomura T, Okazaki T, Okada M, Tsuda Y, Inoue Y, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Inomata Y, Hibi T, Ando Y.

Neurology. 2019 Oct 15;93(16):714-716. doi: 10.1212/WNL.0000000000008320. Epub 2019 Sep 27. No abstract available.

PMID:
31562191
10.

Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More.

Schreiner P, Neurath MF, Ng SC, El-Omar EM, Sharara AI, Kobayashi T, Hisamatsu T, Hibi T, Rogler G.

Inflamm Intest Dis. 2019 Aug;4(3):79-96. doi: 10.1159/000500721. Epub 2019 Jul 9. Review.

11.

A multicenter study of primary liver transplantation for biliary atresia in Japan.

Uto K, Inomata Y, Sakamoto S, Hibi T, Sasaki H, Nio M.

Pediatr Surg Int. 2019 Nov;35(11):1223-1229. doi: 10.1007/s00383-019-04553-7. Epub 2019 Sep 18.

PMID:
31535197
12.

Two-staged biliary reconstruction with temporary complete external biliary drainage as a bailout procedure in a pediatric patient after difficult living donor liver retransplantation.

Yamamoto H, Sugawara Y, Ibuki S, Shimata K, Narita Y, Hibi T.

Intractable Rare Dis Res. 2019 Aug;8(3):214-216. doi: 10.5582/irdr.2019.01081.

13.

Structural and functional characterization of a glycoside hydrolase family 3 β-N-acetylglucosaminidase from Paenibacillus sp. str. FPU-7.

Itoh T, Araki T, Nishiyama T, Hibi T, Kimoto H.

J Biochem. 2019 Dec 1;166(6):503-515. doi: 10.1093/jb/mvz072.

PMID:
31501879
14.

Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network).

Yamazaki H, Matsuoka K, Fernandez J, Hibi T, Watanabe M, Hisamatsu T, Fukuhara S.

BMJ Open. 2019 Sep 8;9(9):e030134. doi: 10.1136/bmjopen-2019-030134.

15.

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.

Sandborn WJ, Ferrante M, Bhandari BR, Berliba E, Feagan BG, Hibi T, Tuttle JL, Klekotka P, Friedrich S, Durante M, Morgan-Cox M, Laskowski J, Schmitz J, D'Haens GR.

Gastroenterology. 2019 Sep 4. pii: S0016-5085(19)41300-0. doi: 10.1053/j.gastro.2019.08.043. [Epub ahead of print]

16.

Infliximab biosimilar CT-P13 is interchangeable with its originator for patients with inflammatory bowel disease in real world practice.

Nakagawa T, Kobayashi T, Nishikawa K, Yamada F, Asai S, Sameshima Y, Suzuki Y, Watanabe M, Hibi T.

Intest Res. 2019 Oct;17(4):504-515. doi: 10.5217/ir.2019.00030. Epub 2019 Aug 23.

17.

Achievement of Durable and Complete Remission of Graft-versus-host Disease After Liver Transplantation With Ruxolitinib: A Case Report.

Endo Y, Oshima G, Hibi T, Shinoda M, Sakurai M, Koda Y, Izawa Y, Obara H, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Fukushima A, Yokose T, Mori T, Kuroda T, Kitagawa Y.

Transplantation. 2019 Nov;103(11):e375-e377. doi: 10.1097/TP.0000000000002904. No abstract available.

PMID:
31397803
18.

Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: a claims database analysis.

Kobayashi T, Udagawa E, Uda A, Hibi T, Hisamatsu T.

J Gastroenterol Hepatol. 2019 Aug 8. doi: 10.1111/jgh.14825. [Epub ahead of print]

PMID:
31397010
19.

Significance of Conducting 2 Types of Fecal Tests in Patients with Ulcerative Colitis.

Naganuma M, Kobayashi T, Nasuno M, Motoya S, Kato S, Matsuoka K, Hokari R, Watanabe C, Sakamoto H, Yamamoto H, Sasaki M, Watanabe K, Iijima H, Endo Y, Ichikawa H, Ozeki K, Tanida S, Ueno N, Fujiya M, Sako M, Takeuchi K, Sugimoto S, Abe T, Hibi T, Suzuki Y, Kanai T.

Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30843-2. doi: 10.1016/j.cgh.2019.07.054. [Epub ahead of print]

20.

Predictive model for survival after liver resection for noncolorectal liver metastases in the modern era: a Japanese multicenter analysis.

Wakabayashi T, Hibi T, Yoneda G, Iwao Y, Sawada Y, Hoshino H, Uemura S, Ban D, Kudo A, Takemura Y, Mishima K, Shinoda M, Itano O, Otsubo T, Endo I, Kitagawa Y, Tanabe M, Egawa H, Yamamoto M.

J Hepatobiliary Pancreat Sci. 2019 Oct;26(10):441-448. doi: 10.1002/jhbp.654. Epub 2019 Jul 28.

PMID:
31271511
21.

Erratum: Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.

Shinzaki S, Matsuoka K, Iijima H, Mizuno S, Serada S, Fujimoto M, Arai N, Koyama N, Morii E, Watanabe M, Hibi T, Kanai T, Takehara T, Naka T.

J Crohns Colitis. 2019 Jun 13. pii: jjz100. doi: 10.1093/ecco-jcc/jjz100. [Epub ahead of print] No abstract available.

PMID:
31222277
22.

Efficacy of repeated balloon venoplasty for treatment of hepatic venous outflow obstruction after pediatric living-donor liver transplantation: A single-institution experience.

Shimata K, Sugawara Y, Honda M, Ikeda O, Tamura Y, Hayashida S, Ohya Y, Yamamoto H, Yamashita Y, Inomata Y, Hibi T.

Pediatr Transplant. 2019 Sep;23(6):e13522. doi: 10.1111/petr.13522. Epub 2019 Jun 18.

PMID:
31210388
23.

A Patient with KL-6 Elevation with Anti-TNFα Who Could Receive Long-Term Use without Interstitial Pneumonia after Class Switch of Anti-TNFα.

Masuda T, Yoshida A, Ueno F, Hara S, Nabeta H, Umezawa S, Shirai M, Morikawa Y, Morizane T, Endo Y, Hibi T.

Inflamm Intest Dis. 2019 May;4(1):35-40. doi: 10.1159/000497778. Epub 2019 Mar 25.

24.

Living Donor Liver Transplantation With a Left Trisection Plus Caudate Lobe Graft.

Ibuki S, Abe Y, Shimata K, Narita Y, Irie T, Yamamoto H, Sugawara Y, Hibi T.

Liver Transpl. 2019 Aug;25(8):1276-1280. doi: 10.1002/lt.25577. Epub 2019 Jun 25. No abstract available.

PMID:
31162780
25.

Single-center Experience of Living-donor Liver Transplantation in Patients Receiving Maintenance Renal Replacement Therapy.

Irie T, Sugawara Y, Narita Y, Ibuki S, Shimata K, Yamamoto H, Hibi T.

Transplant Proc. 2019 Jun;51(5):1520-1521. doi: 10.1016/j.transproceed.2019.01.121.

PMID:
31155186
26.

Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging.

Takahashi N, Yamada Y, Hoshino K, Kawaida M, Mori T, Abe K, Fujimura T, Matsubara K, Hibi T, Shinoda M, Obara H, Isshiki K, Shima H, Shimada H, Kameyama K, Fuchimoto Y, Kitagawa Y, Kuroda T.

Cancers (Basel). 2019 May 26;11(5). pii: E730. doi: 10.3390/cancers11050730.

27.

Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey.

Naganuma M, Sugimoto S, Suzuki H, Matsuno Y, Araki T, Shimizu H, Hayashi R, Fukuda T, Nakamoto N, Iijima H, Nakamura S, Kataoka M, Tamura Y, Tatsumi K, Hibi T, Suzuki Y, Kanai T; INDIGO survey Group.

J Gastroenterol. 2019 Oct;54(10):891-896. doi: 10.1007/s00535-019-01591-9. Epub 2019 May 17.

PMID:
31102012
28.

Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes.

Hayasaki A, Murata Y, Usui M, Hibi T, Fujii T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Uchida K, Isaji S.

Biomed Res Int. 2019 Apr 4;2019:5738614. doi: 10.1155/2019/5738614. eCollection 2019.

29.

Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2).

Hisamatsu T, Kato S, Kunisaki R, Matsuura M, Nagahori M, Motoya S, Esaki M, Fukata N, Inoue S, Sugaya T, Sakuraba H, Hirai F, Watanabe K, Kanai T, Naganuma M, Nakase H, Suzuki Y, Watanabe M, Hibi T, Nojima M, Matsumoto T; DIAMOND2 Study Group.

J Gastroenterol. 2019 Oct;54(10):860-870. doi: 10.1007/s00535-019-01582-w. Epub 2019 Apr 30.

PMID:
31041545
30.

Myelopathy due to human T-cell leukemia virus type-1 from the donor after ABO-incompatible liver transplantation.

Wakabayashi T, Obara H, Seki M, Shinoda M, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Oshima G, Oki K, Nagoshi N, Watanabe K, Hibi T, Itano O, Hoshino K, Suzuki N, Kuroda T, Kitagawa Y.

Ann Hepatol. 2019 Mar - Apr;18(2):397-401. doi: 10.1016/j.aohep.2018.06.002. Epub 2019 Apr 17.

31.

Portal Vein Stent Placement in Living-donor Liver Transplantation: A Single-center Experience.

Narita Y, Sugawara Y, Ibuki S, Irie T, Shimata K, Yamamoto H, Hibi T.

Transplant Proc. 2019 Jun;51(5):1522-1524. doi: 10.1016/j.transproceed.2019.01.123. Epub 2019 Apr 19.

PMID:
31010697
32.

Living donor liver transplantation for a patient with a history of total gastrectomy.

Shimata K, Irie T, Kadohisa M, Kawabata S, Ibuki S, Narita Y, Yamamoto H, Sugawara Y, Hibi T.

Biosci Trends. 2019 May 12;13(2):212-215. doi: 10.5582/bst.2019.01037. Epub 2019 Apr 15.

33.

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.

Motoya S, Watanabe K, Ogata H, Kanai T, Matsui T, Suzuki Y, Shikamura M, Sugiura K, Oda K, Hori T, Araki T, Watanabe M, Hibi T.

PLoS One. 2019 Apr 11;14(4):e0215491. doi: 10.1371/journal.pone.0215491. eCollection 2019.

34.

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.

Motoya S, Watanabe K, Ogata H, Kanai T, Matsui T, Suzuki Y, Shikamura M, Sugiura K, Oda K, Hori T, Araki T, Watanabe M, Hibi T.

PLoS One. 2019 Feb 26;14(2):e0212989. doi: 10.1371/journal.pone.0212989. eCollection 2019. Erratum in: PLoS One. 2019 Apr 11;14(4):e0215491.

35.

Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease.

Sagami S, Kobayashi T, Kikkawa N, Umeda S, Nakano M, Toyonaga T, Okabayashi S, Ozaki R, Hibi T.

PLoS One. 2019 Feb 20;14(2):e0212404. doi: 10.1371/journal.pone.0212404. eCollection 2019.

36.

Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trials.

Ben-Horin S, Zhao Y, Guo J, Mao R, Novack L, Sergienko R, Zhang J, Kobayashi T, Hibi T, Chowers Y, Colombel JF, Peyrin-Biroulet L, Kaplan G, Chen MH.

BMJ Open. 2019 Jan 25;9(1):e024222. doi: 10.1136/bmjopen-2018-024222.

37.

Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study].

Hisamatsu T, Matsumoto T, Watanabe K, Nakase H, Motoya S, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group .

J Crohns Colitis. 2019 Sep 19;13(9):1097-1104. doi: 10.1093/ecco-jcc/jjz030.

PMID:
30753377
38.

Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study.

Hibi T, Motoya S, Ashida T, Sai S, Sameshima Y, Nakamura S, Maemoto A, Nii M, Sullivan BA, Gasser RA Jr, Suzuki Y.

Intest Res. 2019 Jul;17(3):375-386. doi: 10.5217/ir.2018.00141. Epub 2019 Feb 12.

39.

Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation.

Uto K, Sakamoto S, Que W, Shimata K, Hashimoto S, Sakisaka M, Narita Y, Yoshii D, Zhong L, Komohara Y, Li XK, Inomata Y, Hibi T.

BMC Gastroenterol. 2019 Feb 8;19(1):25. doi: 10.1186/s12876-019-0939-7.

40.

The Burden of Diverticular Disease and Its Complications: West versus East.

Imaeda H, Hibi T.

Inflamm Intest Dis. 2018 Dec;3(2):61-68. doi: 10.1159/000492178. Epub 2018 Aug 7. Review.

41.

Individualized treatment based on CYP3A5 single-nucleotide polymorphisms with tacrolimus in ulcerative colitis.

Okabayashi S, Kobayashi T, Saito E, Toyonaga T, Ozaki R, Sagami S, Nakano M, Tanaka J, Yagisawa K, Kuronuma S, Takeuchi O, Hibi T.

Intest Res. 2019 Apr;17(2):218-226. doi: 10.5217/ir.2018.00117. Epub 2019 Feb 7.

42.

Decreased Incidence of Acute Cellular Rejection in Low-Muscle-Mass Recipients After Living-donor Liver Transplantation.

Wakabayashi T, Shinoda M, Obara H, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Oshima G, Hirukawa K, Mizota T, Hibi T, Itano O, Hoshino K, Kuroda T, Kitagawa Y.

Transplant Proc. 2018 Dec;50(10):3626-3634. doi: 10.1016/j.transproceed.2018.06.028. Epub 2018 Jun 30.

PMID:
30577248
43.

Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients.

Yagisawa K, Kobayashi T, Ozaki R, Okabayashi S, Toyonaga T, Miura M, Hayashida M, Saito E, Nakano M, Matsubara H, Hisamatsu T, Hibi T.

Intest Res. 2019 Jan;17(1):87-93. doi: 10.5217/ir.2018.00078. Epub 2018 Dec 14.

44.

Crystal structure analysis and enzymatic characterization of γ-glutamyltranspeptidase from Pseudomonas nitroreducens.

Hibi T, Imaoka M, Shimizu Y, Itoh T, Wakayama M.

Biosci Biotechnol Biochem. 2019 Feb;83(2):262-269. doi: 10.1080/09168451.2018.1547104. Epub 2018 Dec 3.

PMID:
30507352
45.

Drug Lag for Inflammatory Bowel Disease Treatments in the East and West.

Okabayashi S, Kobayashi T, Hibi T.

Inflamm Intest Dis. 2018 Nov;3(1):25-31. doi: 10.1159/000491878. Epub 2018 Oct 5.

46.

Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease.

Sagami S, Kobayashi T, Hibi T.

Inflamm Intest Dis. 2018 Nov;3(1):1-10. doi: 10.1159/000489643. Epub 2018 Jul 17. Review.

47.
48.

X-ray crystallographic analysis of the catalytic domain of α-1,3-glucanase FH1 from Paenibacillus glycanilyticus overexpressed in Brevibacillus choshinensis.

Intuy R, Itoh T, Suyotha W, Hayashi J, Yano S, Makabe K, Wakayama M, Hibi T.

Acta Crystallogr F Struct Biol Commun. 2018 Dec 1;74(Pt 12):770-773. doi: 10.1107/S2053230X18013109. Epub 2018 Nov 16.

PMID:
30511670
49.

Multicenter, retrospective, comparative study of laparoscopic and open Kasai portoenterostomy in children with biliary atresia from Japanese high-volume centers.

Murase N, Hinoki A, Shirota C, Tomita H, Shimojima N, Sasaki H, Nio M, Tahara K, Kanamori Y, Shinkai M, Yamamoto H, Sugawara Y, Hibi T, Ishimaru T, Kawashima H, Koga H, Yamataka A, Uchida H.

J Hepatobiliary Pancreat Sci. 2019 Jan;26(1):43-50. doi: 10.1002/jhbp.594. Epub 2019 Jan 12.

PMID:
30488647
50.

What is transplant oncology?

Hibi T, Sapisochin G.

Surgery. 2019 Feb;165(2):281-285. doi: 10.1016/j.surg.2018.10.024. Epub 2018 Nov 22. Review. No abstract available.

PMID:
30471780

Supplemental Content

Support Center